ArticleCerebrovascular diseases (Basel, Switzerland)2026
Variations across Europe in National Guidelines and Clinical Practice Regarding Screening of Cognitive and Emotional Consequences after Aneurysmal Subarachnoid Hemorrhage.
Article in Cerebrovascular diseases (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionMany survivors of aneurysmal subarachnoid hemorrhage (aSAH) experience cognitive and emotional consequences that negatively affect participation and quality of life. These invisible consequences often go unrecognized making systematic screening important. However, there may be variations across countries in how these consequences are screened for. The aim of the study was to examine variations in guideline recommendations and clinical practice regarding screening of cognitive and emotional consequences after aSAH across Europe.
methodsNational (a)SAH guidelines from 39 European Association of Neurosurgical Societies (EANS) member countries were identified through direct contact with one neurosurgeon per country and additional searches, and were reviewed for recommendations on cognitive and emotional screening. The same representatives were invited for a cross-sectional online survey on clinical screening practices in their center.
resultsEleven of 39 national guidelines (28%) were identified; six recommended cognitive screening, and two emotional screening. Fourteen of 38 members (37%) completed the survey. Nine centers (64%) performed cognitive screening in <50% of patients discharged home from the hospital, three centers (21%) screened 50-89% of patients, and two centers (14%) screened ≥90% of patients. Thirteen centers (93%) performed emotional screening in <50% of patients, and one center (7%) in ≥90% of patients. Timing of screening ranged from before hospital discharge to >8 weeks afterward.
conclusionA minority of European countries seem to have SAH guidelines, and few recommend screening for cognitive and emotional consequences. In most patients, these consequences may remain unscreened. Incorporating routine cognitive and emotional screening into national and local guidelines is crucial to ensure early identification and management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.